# Pre-emptive Pregabalin on Attenuating Maternal Anxiety And Stress Response To Intubation During Caesarean Section

> **NCT04622202** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Zagazig University** · enrollment: 74 (estimated)

## Conditions studied

- Anxiety State
- Sedation

## Interventions

- **DRUG:** Pregabalin 150mg
- **DRUG:** multivitamin

## Key facts

- **NCT ID:** NCT04622202
- **Lead sponsor:** Zagazig University
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-11-15
- **Primary completion:** 2021-02-28
- **Final completion:** 2021-03-01
- **Target enrollment:** 74 (ESTIMATED)
- **Last updated:** 2021-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04622202

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04622202, "Pre-emptive Pregabalin on Attenuating Maternal Anxiety And Stress Response To Intubation During Caesarean Section". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04622202. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*